+ − Summary
+ − Full Texts (3)
+ − Actions (30)
- Governor Approved
- Effective Date January 1, 2020
- Public Act . . . . . . . . . 101-0349
- Sent to the Governor
- Passed Both Houses
- Third Reading - Short Debate - Passed 116-000-000
- Second Reading - Short Debate
- Placed on Calendar Order of 3rd Reading - Short Debate
- Placed on Calendar 2nd Reading - Short Debate
- Do Pass / Short Debate Health Care Licenses Committee; 014-000-000
- Assigned to Health Care Licenses Committee
- Arrived in House
- Third Reading - Passed; 054-000-000
- Chief House Sponsor Rep. Sara Feigenholtz
- First Reading
- Referred to Rules Committee
- Second Reading
- Placed on Calendar Order of 3rd Reading March 27, 2019
- Senate Committee Amendment No. 1 Adopted
- Do Pass as Amended Licensed Activities; 006-000-000
- Placed on Calendar Order of 2nd Reading March 21, 2019
- Senate Committee Amendment No. 1 Assignments Refers to Licensed Activities
- Senate Committee Amendment No. 1 Filed with Secretary by Sen. Michael E. Hastings
- Senate Committee Amendment No. 1 Referred to Assignments
- Postponed - Licensed Activities
- Postponed - Licensed Activities
- Assigned to Licensed Activities
- Filed with Secretary by Sen. Michael E. Hastings
- First Reading
- Referred to Assignments
+ − Adopted Amendment
Senate Amendment 001
Provides that following the initial administration of long-acting or extended-release form opioid antagonists by a physician licensed to practice medicine in all its branches, administration of injections of long-acting or extended-release form opioid antagonists for the treatment of substance use disorder, pursuant to a valid prescription by a physician licensed to practice medicine in all its branches, upon completion of appropriate training, including how to address contraindications and adverse reactions, including, but not limited to, respiratory depression and the performance of cardiopulmonary resuscitation, set forth by rule, with notification to the patient's physician and appropriate record retention, or pursuant to hospital pharmacy and therapeutics committee policies and procedures. Provides that training by a physician licensed to practice medicine in all its branches must be conducted by an Accreditation Council of Pharmaceutical Education accredited provider (rather than the requirement of completing the appropriate training).